BeOne Medicines AG (ONC)
NASDAQ: ONC · Real-Time Price · USD
375.80
-0.57 (-0.15%)
Aug 26, 2026, 4:00 PM EDT - Market closed
BeOne Medicines AG Market Cap
BeOne Medicines AG has a market cap or net worth of $42.73 billion as of August 26, 2026. Its market cap has increased by 25.87% in one year.
Market Cap
42.73B
Enterprise Value
39.68B
1-Year Change
25.87%
Ranking
Category
Stock Price
$375.80
ChartMarket Cap Chart
Since February 3, 2016, BeOne Medicines AG's market cap has increased from $861.90M to $42.73B, an increase of 4,857.55%. That is a compound annual growth rate of 44.69%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 26, 2026 | 42.73B | 27.14% |
| Dec 31, 2025 | 33.61B | 70.71% |
| Dec 31, 2024 | 19.69B | 4.41% |
| Dec 29, 2023 | 18.86B | -17.40% |
| Dec 30, 2022 | 22.83B | -10.17% |
| Dec 31, 2021 | 25.41B | 8.12% |
| Dec 31, 2020 | 23.50B | 133.90% |
| Dec 31, 2019 | 10.05B | 20.62% |
| Dec 31, 2018 | 8.33B | 87.56% |
| Dec 29, 2017 | 4.44B | 342.97% |
| Dec 30, 2016 | 1.00B | 16.34% |
| Feb 3, 2016 | 861.90M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Regeneron Pharmaceuticals | 81.36B |
| argenx SE | 65.40B |
| Moderna | 59.75B |
| Revolution Medicines | 46.18B |
| Royalty Pharma | 35.54B |
| Alnylam Pharmaceuticals | 31.98B |
| BioNTech SE | 28.28B |
| Insmed | 27.16B |